Cargando…

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease with ill-defined pathogenesis, calling for urgent developments of new therapeutic regimens. Herein, we applied PandaOmics, an AI-driven target discovery platform, to analyze the expression profiles of central nervous system (C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pun, Frank W., Liu, Bonnie Hei Man, Long, Xi, Leung, Hoi Wing, Leung, Geoffrey Ho Duen, Mewborne, Quinlan T., Gao, Junli, Shneyderman, Anastasia, Ozerov, Ivan V., Wang, Ju, Ren, Feng, Aliper, Alexander, Bischof, Evelyne, Izumchenko, Evgeny, Guan, Xiaoming, Zhang, Ke, Lu, Bai, Rothstein, Jeffrey D., Cudkowicz, Merit E., Zhavoronkov, Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273868/ https://www.ncbi.nlm.nih.gov/pubmed/35837482 http://dx.doi.org/10.3389/fnagi.2022.914017

Ejemplares similares

Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine
por: Pun, Frank W., et al.
Publicado: (2022)

Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform
por: Olsen, Andrea, et al.
Publicado: (2023)

High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders
por: Mkrtchyan, Garik V., et al.
Publicado: (2022)

Biomedical generative pre-trained based transformer language model for age-related disease target discovery
por: Zagirova, Diana, et al.
Publicado: (2023)

Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery
por: Urban, Anatoly, et al.
Publicado: (2023)

Towards AI-driven longevity research: An overview
por: Marino, Nicola, et al.
Publicado: (2023)

In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
por: Ozerov, Ivan V., et al.
Publicado: (2016)

Adapting Blood DNA Methylation Aging Clocks for Use in Saliva Samples With Cell-type Deconvolution
por: Galkin, Fedor, et al.
Publicado: (2021)

Clinical Trials Targeting Aging
por: Nielsen, Johannes Leth, et al.
Publicado: (2022)

The untapped potential of targeting NRF2 in neurodegenerative disease
por: Chen, Wei-Tai, et al.
Publicado: (2023)

Klotho and calciprotein particles as therapeutic targets against accelerated ageing
por: Kuro-o, Makoto
Publicado: (2021)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Recent Advances on Drug Development and Emerging Therapeutic Agents Through Targeting Cellular Homeostasis for Ageing and Cardiovascular Disease
por: Azam, Tayyiba, et al.
Publicado: (2022)

COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity
por: Naumov, Vladimir, et al.
Publicado: (2021)

A cluster of X-linked miRNAs are de-repressed with age in mouse liver and target growth hormone signaling
por: Petrashen, Anna P., et al.
Publicado: (2023)

The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases
por: Darwish, Samar F., et al.
Publicado: (2023)

Targeting Impaired Nutrient Sensing via the Glycogen Synthase Kinase-3 Pathway With Therapeutic Compounds to Prevent or Treat Dementia: A Systematic Review
por: Matysek, Adrian, et al.
Publicado: (2022)

CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
por: Uckun, Fatih M., et al.
Publicado: (2021)

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
por: Ren, Feng, et al.
Publicado: (2023)

Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients
por: Zhu, Qingsong, et al.
Publicado: (2015)

Quench Analysis of the PANDA Target Spectrometer Solenoid
por: Deelen, Nikkie
Publicado: (2014)

Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
por: Ishiguro, Hiroki
Publicado: (2023)

Replenishing the Aged Brains: Targeting Oligodendrocytes and Myelination?
por: Zhang, Xi, et al.
Publicado: (2021)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021)

Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia
por: Zeng, Peng, et al.
Publicado: (2022)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

Identifying potential drug-target interactions based on ensemble deep learning
por: Zhou, Liqian, et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)

Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease
por: Nizari, Shereen, et al.
Publicado: (2022)

Editorial: Unfolded protein response (UPR): An impending target for multiple neurological disorders
por: Jan, Arif Tasleem, et al.
Publicado: (2022)

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
por: Ravi, Rajani, et al.
Publicado: (2018)

Corrigendum: The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis
por: Majerníková, Nad'a, et al.
Publicado: (2022)

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease
por: León, Rilda, et al.
Publicado: (2023)

The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
por: Li, Jiayue, et al.
Publicado: (2023)

GABA(A) Receptors in Astrocytes Are Targets for Commonly Used Intravenous and Inhalational General Anesthetic Drugs
por: Chung, Woosuk, et al.
Publicado: (2022)

A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
por: Chen, Huiyi, et al.
Publicado: (2022)

Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics
por: Chrienova, Zofia, et al.
Publicado: (2022)

Editorial: Novel mechanisms involved in aging and neurodegeneration: Seeking potential therapeutic targets for neurodegenerative diseases
por: Sanhueza, Mario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8bs2nvhe7qtf9bn4p77matj8hd